Cancer treatment is a step closer to becoming personalised with Mitra, a biotechnology company in Boston, releasing a study on predicting different patients’ clinical response to anti-cancer drugs using a machine learning algorithm.
Medical implants provide numerous benefits to patients who cannot afford to have regular visits from a doctor or travel to their GP. But if they are really going to make an impact in healthcare, they need a power source that's more efficient than batteries.
Genesis R&D (ASX:GEN) will seek a new option to fund an emergence from operational suspension, after potential investor UBNZ's former principal was arrested for bribery
Pharmaceutical manufacturer IDT Australia (ASX:IDT) expects an improved profit result in FY12, despite also projecting a 1H loss
Shares in Cochlear Limited (ASX:COH) have slumped 20% after a product recall announcement
Life sciences company NuSep (ASX:NSP) warned that lower than expected profit at its IQ Software division, and expenses, will likely lead to a $2.5m loss in FY11
Medical diagnostics and biotech company (ASX:AGX) has arranged an early exit from its six-year lease to a superfluous QLD property, in a deal set to save it $170k per year
Aussie biotechnology company, Novogen Limited (ASX: NRT) has announced the appointment of Mark Hinze as the company's new CFO and Operations manager
According to a group of venture capitalists, technology trends to watch for range from social networking to health maintenance and an emergence of new companies.
Life science sector lagging behind in adoption of IT, representing a $17 billion opportunity for IT providers.
A group of international scientists is establishing the framework for a biofuels industry built on open source software and standards-based tools.
Oracle said Monday it is purchasing Relsys International, a maker of drug safety and risk management software, a move that ties into its ongoing strategy to tap verticals.